Companies: 10,795·Total market cap: $144.5T
Sera Prognostics, Inc.

Sera Prognostics, Inc.

SERANASDAQHealthcare● Active
$2.10
$-0.19(-8.30%)
Market Cap$80201029
P/E Ratio
52W High$4.09
52W Low$1.411
Overview

Sera Prognostics, Inc. (SERA) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · SERA · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-0.65sera eps ttm · sera earnings per shareEarnings history
PE Ratio (TTM)sera pe ratio ttm · sera price to earningsPE Ratio deep dive
Revenue (TTM)57000.00sera revenue ttm · sera annual revenueFull revenue history
Dividend YieldNo Dividenddoes sera pay dividends · sera dividend yieldDividend history
Shares Outstanding47.7Msera shares outstanding · sera floatShares outstanding history
Next EarningsAug 5, 2026Est.sera earnings date · sera next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$81000.00▲ +5.19% YoY
202320242025
sera prognostics, inc. revenue · sera revenue 2025
FY 2025Net Income-$31.9M▲ +2.95% YoY
202320242025
sera prognostics, inc. net income · sera profit 2025
FY 2025EPS$-0.67▲ +32.32% YoY
202320242025
sera eps · sera prognostics, inc. earnings per share 2025
TTM:Revenue: $57000.00Net Income: -$32.1MEPS: $-0.65View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy5 analystsis sera a buy · sera analyst rating
Strong Buy
0
Buy
4
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$5.00Low
$2.10Current
$5.50Avg Target161.90% upside
$6.00High
sera price target · sera 12 month forecast

Total: 5 · Buy rate: 80.0%

The SERA analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $5.50, representing +161.90% upside from the current price of $2.10.

Stock Performance

Full History
1D-8.30%
1W+1.94%
1M+11.70%
3M+7.69%
YTD-28.81%
1Y+40.00%
5Y-82.35%

About Sera Prognostics, Inc.

CEOZhenya Lindgardt
IPO DateJul 15, 2021
Employees63
CountryUS

Sera Prognostics, Inc. is a women's health diagnostics firm that focuses on creating, advancing, and bringing to market biomarker tests aimed at improving pregnancy results. Their primary product, the…

what is sera prognostics, inc. · sera stock overview · sera prognostics, inc. company profile · who is sera prognostics, inc. ceo · sera NASDAQ · sera prognostics, inc. headquarters · sera prognostics, inc. business segments

About Stock Overview & Key Data

Sera Prognostics, Inc. (SERA) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Jul 15, 2021. As of the latest trading session, SERA stock price is $2.10, with a market capitalization of $80.2M. The stock has returned +40.00% over the past 12 months and -28.81% year-to-date.

According to 5 Wall Street analysts, the consensus rating for Sera Prognostics, Inc. stock is Buy, with an average 12-month price target of $5.50. In fiscal year 2025, Sera Prognostics, Inc. reported revenue of $81000.00 and net income of -$31.9M. For detailed data — including Sera Prognostics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Sera Prognostics, Inc. (SERA) stock price is $2.10. The stock is traded on NASDAQ under the ticker symbol SERA. The 52-week range is $1.41 – $4.09.

SERA stock priceSERA quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice